Detail akcie NoVacyt online

Business Summary: Novacyt SA is a France-based company providing biotechnological solutions. The Company develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. It provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The Company develops secure automated cytology named NovaPrep Processor System. It offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. It creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.
Financial Summary: BRIEF: For the six months ended 30 June 2024, Novacyt SA revenues increased from L3.3M to L10.3M. Net loss before extraordinary items increased from L8.1M to L17.7M. Revenues reflect Asia Pacific (Region) segment increase from L749K to L2.7M, United Kingdom segment increase from L814K to L2.3M, Europe exl.UK segment increase from L584K to L1.9M. Higher net loss reflects Groupe segment loss increase of 4% to L773K.